Home Newsfeeds Barclays Maintains Underweight on Rackspace Tech, Lowers Price Target to $2

Barclays Maintains Underweight on Rackspace Tech, Lowers Price Target to $2

Barclays analyst Ramsey El-Assal maintains Rackspace Tech (NASDAQ:RXT) with a Underweight and lowers the price target from $4 to $2.

byBenzinga Newsdesk

December 19, 2022

1 minute read

Barclays analyst Ramsey El-Assal maintains Rackspace Tech (NASDAQ:RXT) with a Underweight and lowers the price target from $4 to $2.

Analyst Ratings

Where Norfolk Southern Stands With Analysts

By Benzinga Insights

November 17, 12:04 PM

Norfolk Southern (NYSE:NSC) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

NSC

Regions Financial Q1 Highlights: 22% Revenue Growth, Earnings Miss, Solid Net Interest Income & More

By Nabaparna Bhattacharya

April 21, 7:20 AM

Regions Financial Corporation (NYSE:RF) clocked revenue growth of 22% year over year in the first quarter of FY23 to…

Simply Good Foods Q4 Earnings: Shares Gain On 17% Sales Growth, Margin Expansion And More

By Nabaparna Bhattacharya

October 24, 12:02 PM

The Simply Good Foods Co.'s (NASDAQ: SMPL) fourth-quarter FY23 sales increased 16.9% year over year to $320.418 million, marginally missing the consensus of $320.77 million.

SMPL

X4 Pharma Highlights ‘Significant Reduction’ Rate In Severity, Duration Of Infections

By Vandana Singh

May 17, 9:45 AM

X4 Pharmaceuticals Inc (NASDAQ: XFOR) highlighted new data from a Phase 3 clinical trial of once-daily, oral mavorixafor in

XFOR

Barclays Maintains Underweight on Rackspace Tech, Lowers Price Target to $2

Related Posts

Where Norfolk Southern Stands With Analysts

Regions Financial Q1 Highlights: 22% Revenue Growth, Earnings Miss, Solid Net Interest Income & More

Simply Good Foods Q4 Earnings: Shares Gain On 17% Sales Growth, Margin Expansion And More

X4 Pharma Highlights ‘Significant Reduction’ Rate In Severity, Duration Of Infections